CVRx® Appoints New Chief Marketing Officer and Vice President of European Sales and Marketing
January 05, 2021 10:55 ET | CVRx, Inc.
MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that it is expanding...
cb-scientific-inc-logo-black.png
CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021
December 28, 2020 06:30 ET | CB Scientific, Inc.
ESCONDIDO, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory...
Reports and Data.jpeg-01
Medical Digital Imaging Systems Market Size Worth USD 29.97 Billion By 2027 | Reports and Data
December 14, 2020 08:04 ET | Reports and Data
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) -- The rising demand for disease diagnosis at an early stage is one of the significant factors influencing the medical digital imaging systems market growth....
CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status
December 03, 2020 11:54 ET | CVRx, Inc.
MINNEAPOLIS, Dec. 03, 2020 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that the Centers for...
CVRx® Announces New CFO and Acceleration of Barostim Therapy Commercialization Efforts
November 18, 2020 14:56 ET | CVRx, Inc.
MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- CVRx, Inc., developer of FDA-approved Barostim Therapy to treat chronic heart failure (HF), announced a CFO transition as part of the company’s...
cb-scientific-inc-logo-black.png
CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
November 12, 2020 07:30 ET | CB Scientific, Inc.
ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights
November 10, 2020 07:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of autologous and allogenic cell therapies, today reported financial results and...
ASE Announces Its 2020-22 Leadership Academy Cohort
October 19, 2020 08:00 ET | American Society of Echocardiography
Durham, North Carolina, Oct. 19, 2020 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) is pleased to announce that 15 members have been chosen to make up the second cohort of the...
DEFINE PCI study one-year data show potential of treating residual ischemia to improve clinical outcomes for coronary stent patients
October 15, 2020 13:00 ET | Royal Philips
October 15, 2020 New data suggest that PCI guided by iFR co-registered on the angiogram can improve outcomes and reduce angina for patients more effectively than treatment guided by angiography...
cb-scientific-inc-logo-black.png
CB Scientific, Inc. (CBSC) Announces the Launch of My-Cardia ECG Products and Services in Thailand
October 08, 2020 08:00 ET | CB Scientific, Inc.
ESCONDIDO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- via Network Wire -- CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory...